BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2014 6:36:00 PM | Browse: 1081 | Download: 1301
 |
Received |
|
2014-03-28 09:07 |
 |
Peer-Review Started |
|
2014-03-28 11:18 |
 |
To Make the First Decision |
|
2014-04-28 14:14 |
 |
Return for Revision |
|
2014-05-03 19:33 |
 |
Revised |
|
2014-05-04 05:20 |
 |
Second Decision |
|
2014-06-26 17:12 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-06-26 17:16 |
 |
Articles in Press |
|
2014-06-26 17:47 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-09 18:31 |
 |
Publish the Manuscript Online |
|
2014-10-20 18:35 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Angelo Alves de Mattos, Ane Micheli Costabeber, Livia Caprara Lionço and Cristiane Valle Tovo |
Funding Agency and Grant Number |
|
Corresponding Author |
Cristiane Valle Tovo, MD, PhD, Department of Gastroenterology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Cel Aurélio Bitencourt 115, Apt. 201, Porto Alegre 90430-080, Brazil. cris.tovo@terra.com.br |
Key Words |
Spontaneous peritonitis; Multi-resistant bacteria; Cirrhosis; Infection; Ascites |
Core Tip |
Spontaneous bacterial peritonitis (SBP) is the most typical infection observed in cirrhosis patients. The increasing trend of bacterial resistance development in cirrhotic patients with SBP has been associated with a low treatment efficacy of traditional therapy in nosocomial infections. The use of a broad empirical spectrum antibiotic has been suggested as an alternative. Cephalosporin use should be restricted to community-acquired infections, while changes are necessary with regard to empiric therapy recommendations. Broad-spectrum antimicrobial agents, such as carbapenems with or without glycopeptides or piperacillin-tazobactam, should be considered for the initial treatment of nosocomial infections. |
Publish Date |
2014-10-20 18:35 |
Citation |
Mattos AA, Costabeber AM, Lionço LC, Tovo CV. Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management? World J Gastroenterol 2014; 20(39): 14079-14086 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i39/14079.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i39.14079 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345